Noctis Noc (Doxylamine Hydrogen Succinate)

Doxylamine works by competitively blocking H1 histamine receptors in both peripheral tissues and the central nervous system. This antagonism reduces the actions of histamine that cause allergy symptoms and also produces a sedative effect that promotes sleep.

The appropriate dose of Noctis Noc is determined by a qualified healthcare professional based on the individual’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety information for doxylamine in pregnancy and lactation is limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their doctor before using Noctis Noc.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both doxylamine and diphenhydramine are first‑generation antihistamines with sedative properties. Doxylamine generally has a longer half‑life, which may provide more sustained sleep support, while diphenhydramine may wear off earlier. Individual response varies, so clinicians choose the agent that best fits the patient’s needs.

Store Noctis Noc at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, direct sunlight and excessive heat to maintain potency.

Noctis Noc is taken orally, usually with a full glass of water. It is intended for short‑term use, and patients should follow the timing and dosing instructions provided by their prescriber.

Serious adverse reactions, although rare, include anaphylaxis, severe cardiac arrhythmias, seizures, and hallucinations. Anyone experiencing these symptoms should seek immediate medical attention.

Individuals with known hypersensitivity to doxylamine or other first‑generation antihistamines, patients with severe glaucoma, urinary retention, or uncontrolled asthma, and those taking certain CNS depressants should avoid Noctis Noc unless advised otherwise by a healthcare professional.